Third Generation EGFR TKIs for Acquired Resistance episode artwork

EPISODE · Feb 17, 2016 · 3 MIN

Third Generation EGFR TKIs for Acquired Resistance

from GRACEcast · host cancerGRACE Meetings

Dr. Nathan Pennell, Cleveland Clinic, discusses the concept of acquired resistance and new agents designed to address it, including Rociletinib and Merelitinib.

Episode metadata supplied by the publisher feed · Published Feb 17, 2016

Embed this episode

NOW PLAYING

Third Generation EGFR TKIs for Acquired Resistance

0:00 3:07

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of GRACEcast?

This episode is 3 minutes long.

When was this GRACEcast episode published?

This episode was published on February 17, 2016.

Can I download this GRACEcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!